REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,685,528 | +199.9% | 205,402 | +189.8% | 0.00% | – |
| Q2 2023 | $1,895,666 | +44.6% | 70,866 | +17.1% | 0.00% | – |
| Q1 2023 | $1,310,820 | +106.9% | 60,518 | +127.6% | 0.00% | – |
| Q4 2022 | $633,445 | +19.5% | 26,593 | -1.2% | 0.00% | – |
| Q3 2022 | $530,000 | +17.8% | 26,922 | +16.6% | 0.00% | – |
| Q2 2022 | $450,000 | -23.2% | 23,085 | +0.6% | 0.00% | – |
| Q1 2022 | $586,000 | +2.3% | 22,939 | +0.9% | 0.00% | – |
| Q4 2021 | $573,000 | +5.5% | 22,733 | +15.1% | 0.00% | – |
| Q3 2021 | $543,000 | -27.6% | 19,749 | -16.4% | 0.00% | – |
| Q2 2021 | $750,000 | +80.7% | 23,622 | +160.9% | 0.00% | – |
| Q1 2021 | $415,000 | -38.9% | 9,054 | -47.2% | 0.00% | – |
| Q4 2020 | $679,000 | +30.3% | 17,153 | +4.1% | 0.00% | – |
| Q2 2020 | $521,000 | – | 16,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |